Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China; Shenzhen Huazhong University of Science and Technology Research Institute, Shenzhen, China.
Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China.
Mol Ther. 2020 Jul 8;28(7):1658-1672. doi: 10.1016/j.ymthe.2020.04.023. Epub 2020 Apr 29.
Clear-cell renal cell carcinoma (ccRCC) is the most common histological type of RCC. To investigate the intratumoral heterogeneity of ccRCC, we analyzed single-cell RNA-sequencing data and identified 15 major cell types, along with 39 subgroups of cells derived from tumor or non-malignant tissues, and confirmed their presence by immunofluorescence staining in tissue chips. In this study, we verified that T cell exhaustion was the key factor responsible for the immunosuppressive property of ccRCC tissues, which was significantly related to poor prognosis. We also found that abnormal metabolic patterns occurred not only in cancer cells, but also in tumor-infiltrating stromal cells. Based on the fraction of each cell cluster detected by CIBERSORTx, 533 patients from The Cancer Genome Atlas (TCGA) KIRC dataset were divided into three groups. One group, which showed a lesser proportion of activated CD8 cells and greater proportion of exhausted CD8 cells, was associated with a poor prognosis. Hence, the blockade of immunosuppressive checkpoints, not only PD-1, but also LAG3, TIM-3, and other inhibitory checkpoints, could serve as a potential target for ccRCC immunotherapy. Our work will further the understanding of the heterogeneity among ccRCC tissues and provide novel strategies for treating ccRCC.
透明细胞肾细胞癌(ccRCC)是 RCC 中最常见的组织学类型。为了研究 ccRCC 的肿瘤内异质性,我们分析了单细胞 RNA 测序数据,鉴定出 15 种主要细胞类型,以及 39 个源自肿瘤或非恶性组织的细胞亚群,并通过组织芯片中的免疫荧光染色证实了它们的存在。在这项研究中,我们验证了 T 细胞耗竭是 ccRCC 组织免疫抑制特性的关键因素,这与预后不良显著相关。我们还发现异常代谢模式不仅发生在癌细胞中,也发生在肿瘤浸润的基质细胞中。基于 CIBERSORTx 检测到的每个细胞簇的比例,从癌症基因组图谱(TCGA)KIRC 数据集的 533 名患者被分为三组。一组表现出较少比例的激活 CD8 细胞和较多比例的耗竭 CD8 细胞,与预后不良相关。因此,抑制免疫检查点,不仅是 PD-1,还有 LAG3、TIM-3 和其他抑制性检查点,可能成为 ccRCC 免疫治疗的潜在靶点。我们的工作将进一步加深对 ccRCC 组织异质性的理解,并为治疗 ccRCC 提供新的策略。